XML 27 R33.htm IDEA: XBRL DOCUMENT v3.20.1
INCOME TAXES (Tables)
12 Months Ended
Dec. 31, 2019
Income Tax Disclosure [Abstract]  
Schedule of Income (Loss) before Taxes on Income

b.Loss before taxes on income is comprised as follows:

Year ended December 31,

2017

2018

2019

 

Domestic

$

(53,432

)

$

(50,679

)

$

(85,369)

Foreign

(1,518

)

16,766

1,553

 

Loss before taxes on income

$

(54,950

)

$

(33,913

)

$

(83,816

)

Schedule of Deferred Income Taxes

Deferred taxes reflect the net tax effect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts recorded for tax purposes. Significant components of the Company's deferred tax assets and liabilities are as follows:

December 31,

2018

2019

Deferred tax assets:

 

Net operating loss carryforward

$

45,314

$

34,400

Capital losses carry-forwards

53

59

Operating lease tax assets

11,376

Research and development expenses

1,901

4,011

Depreciation difference

1,680

2,074

Accrued employees costs

2,176

3,057

Tax advances

-

3,353

Intra-entity intellectual property transfer(1)

-

3,516

Other

964

468

 

Deferred tax assets, net before valuation allowance

52,088

62,314

 

Valuation allowance

(44,607

)

(45,465)

 

Deferred tax asset, net

$

7,481

$

16,849

 

Deferred tax liabilities:

 

Property and equipment

$

306

$

322

Operating lease tax liabilities

11,376

Acquired Intangible assets

5,556

1,945

Share-based compensation

467

1,305

Other

171

209

 

Deferred tax liabilities

$

6,500

$

15,157

 

Deferred taxes are included in the consolidated balance sheets, as follows:

 

Long-term receivables

$

1,583

$

14,730

 

Long-term liabilities

$

602

$

13,036

 

(1)During 2019, the Company completed an intra-entity transfer from US to Israel of certain intangible property (“IP”) rights associated with a subsidiary’s technology platform. This transfer resulted in an income tax expense for US tax purposes of approximately $15,000. As a result of the IP transfer, the Company utilized NOLs and consequently released the valuation allowance.

Schedule of Income Taxes

d.Income taxes are comprised as follows:

Year ended December 31,

2017

2018

2019

 

Current

$

4,042

$

4,188

$

3,309

Deferred

(2,719

)

(981

)

(711)

 

$

1,323

$

3,207

$

2,598

 

Domestic

$

578

$

1,140

$

(1,981)

Foreign

745

2,067

4,579

 

$

1,323

$

3,207

$

2,598

Reconciliation of Effective Tax Rate to Statutory Rate

e.A reconciliation of the Company's theoretical income tax expense to actual income tax expense as follows:

Year ended December 31,

2017

2018

2019

 

Loss before taxes on income

$

(54,950

)

$

(33,913

)

$

(83,816)

 

Statutory tax rate

24

%

23

%

23

%

 

Theoretical income tax expense

(13,188

)

(7,800

)

(19,278)

 

Change in valuation allowance

2,122

(1,925

)

(1,821)

Non-deductible option expenses

8,528

12,609

20,882

Non-deductible expenses

1,263

824

728

Tax adjustment in respect of different tax rate of foreign subsidiary

(1,679

)

(1,627

)

2,894

Rate change impact

3,099

(174

)

(90)

Intra-entity intellectual property transfer

-

-

196

Foreign tax

881

1,182

102

Other

297

118

(1,015)

 

Income tax expense

$

1,323

$

3,207

$

2,598

Schedule of reconciliation of the opening and closing amounts of total unrecognized tax benefits

A reconciliation of the opening and closing amounts of total unrecognized tax benefits is as follows:

 

 

Year ended December 31,

 

 

 

2017

2018

 

 

2019

 

 

 

 

 

 

 

 

 

Opening balance

 

$

1,098

 

 

$

1,378

 

 

$

334

 

Increases (decrease) related to previous and current year tax positions

 

 

280

 

(1,044

)

 

 

1,696

 

 

 

 

 

 

 

 

 

 

Closing balance

 

$

1,378

$

334

 

 

$

2,030